arrow
A

Adrian V. Lee

upmc hillman cancer center
H指数:85
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MOSAIC: Intra-tumoral heterogeneity characterization through large-scale spatial and cell-resolved multi-omics profiling

MOSAIC:通过大规模空间和单细胞解析的多组学分析表征肿瘤内异质性

2026-10-070
OAAI
Quantitative and qualitative patient-reported analysis of misdiagnosis and/or late diagnosis of metastatic lobular cancer

对转移性小叶癌误诊和/或延迟诊断的定量与定性患者报告分析

2026-08-120
OAAI
A dependency map enhanced with next-generation 3D cancer models

一张融合了新一代3D癌症模型的药物靶点互作图

Nature
IF48.5
2026-08-050
OA
Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women
2026-07-270
OA
Clinical and histopathological characterization of metastatic lobular breast cancer: lessons learned from post-mortem tissue donation programs

转移性小叶乳腺癌的临床与组织病理学特征:来自尸检组织捐赠项目的经验教训

2026-02-200
OAAI
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer

整合人工智能驱动的数字病理学和基因组学,以建立基于患者来源的类器官作为头颈癌药物反应的新方法学。

2025-11-090
OAAI
Vaccine-induced immunity is maintained in glioma patients relative to other solid tumours

疫苗诱导的免疫在胶质瘤患者中维持,与其他实体瘤相比。

2025-10-150
OA
Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer

靶向CDK12破坏雌激素受体染色质募集和ER-MED1转录在晚期ER+乳腺癌中的作用

2025-10-150
OAAI
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination

实体瘤恶性患者中失调的炎症塑造了针对COVID-19疫苗接种的多功能抗体反应

2025-10-060
OA
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy

p95HER2,HER2癌蛋白的一种截断形式,在HER2+乳腺癌中驱动一种免疫抑制程序,限制了T-DXd(trastuzumab deruxtecan)的疗效。

2025-06-270
PRE
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research

MBCRC倡导者研究员计划 (MARP): 将倡导者和研究人员作为癌症研究的合作伙伴

2025-06-210
OAAI
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
2025-01-240
OAAI